<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Alveolopleural fistula and prolonged air leak in adults</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Alveolopleural fistula and prolonged air leak in adults</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Alveolopleural fistula and prolonged air leak in adults</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Adnan Majid, MD, FCCP</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Fayez Kheir, MD, MSc</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Henri G Colt, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Geraldine Finlay, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 16, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1000924692"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>An alveolopleural fistula (APF) is a pathologic communication between the pulmonary parenchyma distal to a segmental bronchus (alveoli) and the pleural space. It presents as a pneumothorax and if it persists beyond five days is labeled as a prolonged air leak (PAL). PAL is associated with significant morbidity and prolonged hospitalization.</p><p>The evaluation and management of APF with a PAL is discussed here. Diagnosis and management of tracheoesophageal and bronchopleural fistula are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/115897.html" rel="external">"Bronchopleural fistula in adults"</a> and  <a class="medical medical_review" href="/z/d/html/115157.html" rel="external">"Tracheo- and broncho-esophageal fistulas in adults"</a>.)</p><p class="headingAnchor" id="H623510313"><span class="h1">ETIOLOGY</span><span class="headingEndMark"> — </span>APF and PALs are most commonly seen in patients following lung volume reduction surgery (up to 46 percent) and pulmonary resection or biopsy (3 percent following wedge resection) but can also be seen following spontaneous pneumothorax [<a href="#rid1">1-3</a>]. Less common causes include pulmonary infections (eg, necrotizing pneumonia), malignancies (eg, pulmonary metastasis), pleural drainage procedures, barotrauma due to mechanical ventilation, chest trauma, and iatrogenic etiologies that can occur after thoracentesis or chest tube insertion (ie, pleural drainage procedures). (See  <a class="medical medical_review" href="/z/d/html/1592.html" rel="external">"Diagnosis, management, and prevention of pulmonary barotrauma during invasive mechanical ventilation in adults"</a>.)</p><p class="headingAnchor" id="H1506249123"><span class="h1">RISK FACTORS</span><span class="headingEndMark"> — </span>In the setting of lung resection (robotic- or video-assisted, open) or lung volume reduction surgery, several risk factors for APF with PAL have been reported [<a href="#rid1">1,2,4,5</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Chronic obstructive pulmonary disease or other underlying lung disease</p><p class="bulletIndent1"><span class="glyph">●</span>Female sex</p><p class="bulletIndent1"><span class="glyph">●</span>Low forced expiratory volume in one second or diffusing capacity for carbon monoxide</p><p class="bulletIndent1"><span class="glyph">●</span>History of smoking</p><p class="bulletIndent1"><span class="glyph">●</span>Diabetes mellitus</p><p class="bulletIndent1"><span class="glyph">●</span>Chronic steroid use</p><p class="bulletIndent1"><span class="glyph">●</span>Marked pleural adhesions noted during surgery</p><p class="bulletIndent1"><span class="glyph">●</span>Upper lobe emphysema or diffuse emphysema</p><p class="bulletIndent1"><span class="glyph">●</span>Increased age</p><p class="bulletIndent1"><span class="glyph">●</span>Large bullae</p><p></p><p>Although likely, it is unknown whether similar risk factors promote APF with PAL in nonsurgical populations.</p><p class="headingAnchor" id="H2107389800"><span class="h1">CLINICAL FEATURES</span><span class="headingEndMark"> — </span>There are no specific signs or symptoms associated with PAL, but some patients have a persistent pneumothorax on chest imaging. Although APFs can theoretically cause hypercapnia due to loss of alveolar ventilation through the air leak, this is rare in clinical practice. This is probably because the leaked gas participates in gas exchange rather than being lost or wasted [<a href="#rid6">6</a>]. Intractable respiratory acidosis and other serious complications are more likely due to the lung disease than the APF.</p><p class="headingAnchor" id="H4099427013"><span class="h1">EVALUATION AND MANAGEMENT</span><span class="headingEndMark"> — </span>An APF should be suspected in a patient with risk factors who has a PAL seen on chest tube drainage system for greater than five days. Continued flow through the fistula to the pleural space delays healing and prevents lung expansion; the longer air flows through the fistula, the more likely it is to remain patent. Thus, prompt reduction in the flow of air is critical for effective management. APF-associated PALs are not fatal but are associated with prolonged hospital stays, higher rates of intensive care unit admission, and high morbidity (eg, pneumonia, empyema, venous thromboembolism) [<a href="#rid1">1,2</a>].</p><p>There is a paucity of data and no consensus or guidelines on how best to manage APF with PAL. Significant variation among clinicians exists, but practice is evolving as expertise in interventional pulmonary grows. The approach outlined here is influenced by our expertise in interventional pulmonology, and we recognize that this strategy may not always be universally applied, particularly when interventional expertise is not available.</p><p>Air leak can be classified into drainage-dependent (also known as pressure-dependent) and drainage-independent (also known as pressure-independent) air leaks [<a href="#rid7">7,8</a>]. This is typically determined with pleural manometry, which is a technique that can directly measure the pleural pressures and differentiate between these two types of air leaks. The majority of patients with PAL following partial lung resection have drainage-dependent air leak. These patients have shorter hospital length of stay and less need for reexploration surgery compared with patients with drainage-independent air leak [<a href="#rid9">9</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>Drainage-dependent air leak typically occurs in patients with nonexpandable lung where air leak continues only during the chest tube drainage process and stops when drainage is discontinued. This is caused by shape mismatch between the lung and thoracic cavity due to visceral pleural restriction. During drainage, excessively negative pleural pressure leads to a significant distortion of the subpleural alveolar units, resulting in the formation of the transient pressure-dependent APF and thereby formation of pneumothorax [<a href="#rid7">7,8</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Drainage-independent air leak occurs due to direct visceral pleural injury, and the air leak persists even if the drainage process is discontinued. This is due to a continual rise in the pleural pressure leading to an increase in the size of the pneumothorax.</p><p></p><p class="headingAnchor" id="H3908236521"><span class="h2">General supportive care (drainage of air)</span><span class="headingEndMark"> — </span>Most patients with PAL respond to conservative therapy (up to 80 percent in our experience). This involves continued chest tube thoracostomy with low wall suction to promote lung expansion and pleural apposition. In some cases with large fistulas (eg, secondary spontaneous pneumothorax in patients with chronic obstructive pulmonary disease secondary to rupture of large bullae), the addition of high suction and even insertion of a second chest tube may be warranted. In contrast, in patients with nonexpandable lung (trapped or entrapped lung (see  <a class="medical medical_review" href="/z/d/html/6697.html" rel="external">"Diagnosis and management of pleural causes of nonexpandable lung"</a>)), suction should be avoided. Patients should also receive adequate nutrition and appropriate antibiotic therapy (if indicated), and therapy for comorbidities should be optimized. For patients who are mechanically ventilated, lowering the level of positive pressure and selective intubation of the healthy lung is appropriate, the details of which are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1649.html" rel="external">"Management of persistent air leaks in patients on mechanical ventilation"</a>.)</p><p>It is controversial whether or not suction should be applied. On one hand, some experts, including us, apply low wall suction to increase adherence of the visceral and parietal membranes, thereby promoting healing and closure of the fistula. In contrast, other experts avoid suction believing that suction promotes continued patency. The latter practice is supported by studies of patients in whom routine suction is applied immediately postoperatively that have suggested a reduced incidence of APF with PAL in patients whose chest tubes were placed on water seal compared with suction [<a href="#rid10">10-13</a>]. However, none of these studies have been performed in patients with PAL from other etiologies. In addition, arguing against the practice of avoiding suction is our belief that healing of the visceral pleural membrane is considerably less likely to occur if not apposed with the parietal membrane. Thus, we apply suction but minimize it when possible, especially in patients with nonexpandable lungs (trapped or entrapped lung) with PALs.</p><p>There is no optimal follow-up time for patients who undergo conservative therapy. Nonetheless, in general, smaller PALs that are improving with time (at minimum five days and occasionally up to two weeks) are more likely to spontaneously undergo closure with conservative management than larger air leaks that have been present for a prolonged period of time and are not improving despite conservative therapy; the latter are unlikely to resolve spontaneously and require intervention.</p><p>Although the exact proportion is unknown, in our experience, approximately 20 percent of patients will fail conservative therapy and require some form of intervention. The presence of a severe air leak (see <a class="local">'Quantifying the air leak'</a> below), incomplete lung expansion on chest computed tomography (CT), and/or underlying lung disease (such as emphysema, interstitial lung disease, cancer) can probably predict the need of additional intervention for fistula closure.</p><p class="headingAnchor" id="H1087049412"><span class="h2">Patients who fail supportive care</span><span class="headingEndMark"> — </span>Options for fistula closure in patients who fail conservative therapy include ambulatory nonendoscopic devices, bronchoscopic methods, pleural procedures, or surgery. Choosing among these depends upon the available expertise and individual preferences  (<a class="graphic graphic_algorithm graphicRef117795" href="/z/d/graphic/117795.html" rel="external">algorithm 1</a>). With the exception of patients with spontaneous pneumothorax, who in general should undergo video-assisted thoracoscopic surgical (VATS) blebectomy and mechanical pleurodesis, we prefer a systematic approach that measures the size, location, and integrity of the interlobar fissure of the affected lobe with the APF. Our preference is based upon the rationale that it identifies those suitable for bronchoscopic closure, thereby allowing optimal selection of therapeutic options. For example, leaks associated with minimal collateral ventilation between the target lobe and adjacent lobes are better suited to bronchoscopic therapy, while large leaks associated with significant collateral ventilation might be suited for surgical repair or pleural procedures, depending on clinical status of the patient.</p><p class="headingAnchor" id="H1408894376"><span class="h3">Quantifying the air leak</span><span class="headingEndMark"> — </span>The quantification of air leak is important to assess whether the leak will spontaneously resolve with additional supportive care or need more aggressive intervention. In general, small air leaks resolve spontaneously, whereas larger leaks require intervention, although what constitutes small versus large is not clearly defined. Air leaks can be quantified using several methods. We prefer digital drainage system devices since they may be more accurate with less interobserver variability and are easy to use.</p><p>Methods include:</p><p class="bulletIndent1"><span class="glyph">●</span>Digital chest drainage system devices – Digital chest drainage system devices can display the flow (mL/min) of air into the pleural space along with the pleural pressure difference in real time [<a href="#rid14">14</a>]. These devices are not always available but are being increasingly used by thoracic surgeons and interventional pulmonologists instead of standard commercially available drainage systems. The digital system works by maintaining the intrapleural pressure at a steady level within 0.1 cm H<sub>2</sub>O. The regulated suction adjusts according to the condition or need in the pleural cavity. The device will apply suction to keep the pleural cavity at the present level. If the patient does have an air leak with suction, the device will intermittently apply suction to restabilize the pleural space according to the degree of the air leak. The chest tube can be removed when there is no flow or air leak flow is less than 20 mL/min without large variation for at least six hours as measured by digital chest drainage system. Limited data suggest that for patients with an air leak from spontaneous pneumothorax, digital drainage systems were associated with a shorter length of stay and chest tube duration compared with analog systems [<a href="#rid15">15</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Air leak meter – The air leak meter on commercially available chest drainage systems can measure leak on a scale from 1 to 7, with the number representing the columns through which bubbling occurs (the higher the number, the greater the leak)  (<a class="graphic graphic_figure graphicRef117764" href="/z/d/graphic/117764.html" rel="external">figure 1</a>) [<a href="#rid16">16</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Observation using timing during the respiratory cycle – Some experts grade air leak from mild to severe when the leak occurs during forced expiration (grade 1), passive expiration only (grade 2), inspiratory only (grade 3), or inspiration and expiration (grade 4), with grade 1 being the least and grade 4 being the worst leak [<a href="#rid10">10</a>].</p><p></p><p class="headingAnchor" id="H4257916133"><span class="h3">Localizing the air leak (sequential balloon occlusion)</span><span class="headingEndMark"> — </span>Sequential balloon occlusion through flexible bronchoscopy is a useful method to locate the bronchial segment or subsegment that is supplying the APF [<a href="#rid17">17</a>]. A balloon (eg, a Fogarty balloon of appropriate size, typically 5 French) is placed endobronchially through the working channel and inflated to first occlude the main stem bronchus for up to two minutes; a significant reduction in air leak observed through the chest tube drainage system indicates that the bronchus selected leads to the defect. The operator subsequently repeats this step, moving distally through lobar, segmental, and subsegmental bronchi until the target lobe with the fistula is reached.</p><p class="headingAnchor" id="H2949265794"><span class="h3">Evaluation of fissure completeness</span><span class="headingEndMark"> — </span>While some lobes in the lung are fissurally contained, others communicate with adjacent lobes (also known as incomplete fissure or collateral ventilation), a phenomenon that is more common in patients with emphysema. The degree of collateral ventilation should be evaluated to determine whether bronchoscopic methods will be effective. While patients with evidence of an incomplete fissure may not be suitable for bronchoscopic methods, some patients in this category who undergo bronchoscopic treatment may be able to transition to water seal, allowing them to be discharged on a one-way valve (eg, Heimlich valve).</p><p class="bulletIndent1"><span class="glyph">●</span>Sequential balloon testing – Sequential balloon testing not only localizes the air leak (see <a class="local">'Localizing the air leak (sequential balloon occlusion)'</a> above), but once the target lobe is identified, it can also be used to assess collateral ventilation as an indicator of fissure completeness. On sequential balloon testing, a reduction in airflow of ≥50 percent (either estimated as bubbles per minute or measured with a digital chest drainage system) indicates that the APF may be responsive to bronchoscopic management [<a href="#rid18">18</a>]. If a reduction in airflow of &lt;50 percent is observed, then significant collateral ventilation (ie, incomplete lung fissure) between the target and ipsilateral lobes is likely, and bronchoscopic treatment may not be effective [<a href="#rid19">19</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>High-resolution CT of the chest – Fissure completeness between target and ipsilateral lobes can also be evaluated by direct visual assessment of high-resolution chest CT images of the lobar fissures  (<a class="graphic graphic_diagnosticimage graphicRef117765" href="/z/d/graphic/117765.html" rel="external">image 1</a>) and/or quantified by chest CT image analysis software  (<a class="graphic graphic_figure graphicRef117766" href="/z/d/graphic/117766.html" rel="external">figure 2</a>) [<a href="#rid19">19,20</a>]. Fissure integrity &gt;90 percent suggests minimal collateral ventilation and indicates that the APF may be responsive to bronchoscopic management [<a href="#rid18">18</a>]. If fissure integrity ≤90 percent is observed, then significant collateral ventilation (ie, incomplete lung fissure) between the target and ipsilateral lobes is likely, and bronchoscopic treatment may not be effective.</p><p></p><p class="headingAnchor" id="H1243673847"><span class="h3">Minimal collateral ventilation and significant air leak reduction on bronchial occlusion</span><span class="headingEndMark"> — </span>Air leaks with minimal collateral ventilation (eg, &gt;90 percent complete (see <a class="local">'Evaluation of fissure completeness'</a> above)) that also demonstrate a ≥50 reduction in airflow with bronchial occlusion (see <a class="local">'Localizing the air leak (sequential balloon occlusion)'</a> above) are suitable for bronchoscopic methods of fistula closure.</p><p class="headingAnchor" id="H2984175483"><span class="h4">Bronchoscopic interventions</span><span class="headingEndMark"> — </span>Several options are available, none of which are proven to be superior over the other. Data to support these methods are generally derived from case reports or case series. Among the options, we prefer endobronchial valves because they are the best studied and easy to place and remove:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Endobronchial valves</strong>  (<a class="graphic graphic_figure graphicRef117648" href="/z/d/graphic/117648.html" rel="external">figure 3</a>) – Unidirectional airway devices are available in different sizes (5, 6, 7, and 9 mm) that can be placed in lobar, segmental, or subsegmental bronchi using a flexible therapeutic bronchoscope with a 2.8 mm diameter working channel. Some commercial devices come with balloon kits to determine the optimal size. These airway valves limit airflow to portions of the lung distal to their placement while permitting mucous and air movement in the proximal direction, thereby reducing airflow through the fistula and allowing the defect to heal. Based upon studies, typically two to three valves are needed to control the air leak. Endobronchial valves have been approved by the US Food and Drug Administration to treat APFs through a humanitarian device exemption.</p><p></p><p class="bulletIndent1">Case reports and case series consistently show a complete or near-complete resolution of air leak in the majority of patients with valve placement [<a href="#rid21">21-26</a>]. In the largest trial of 75 patients with APF and PAL who underwent valve implantation, air leak resolution occurred in 70 percent of patients with a median time to resolution of 16 days [<a href="#rid26">26</a>]. Additional subsequent procedures were needed in 20 percent of patients (eg, Heimlich valve, chemical pleurodesis). Two patients experienced complications, including empyema and contralateral pneumothorax. Another study has shown similar utility for valves in the closure of AFP with PAL associated with mechanical ventilation [<a href="#rid24">24</a>].</p><p></p><p class="bulletIndent1">PAL treatment with endobronchial valves is more successful in patients without collateral ventilation, especially when complete lobar occlusion was achieved. One study examined the utility of assessing the integrity of the interlobar fissure to predict successful resolution of the PAL. This multicenter retrospective study of 26 patients included 16 patients without collateral ventilation and 10 patients with collateral ventilation. Of the 16 patients without collateral ventilation, 14 had complete resolution of the PAL, with a median time from endobronchial valve placement to air leak resolution of 4.5 days (three days with complete lobar occlusion versus 6.5 days with incomplete lobar occlusion), and 2 patients required additional procedures to achieve resolution of the PAL. Among the remaining 10 patients with collateral ventilation, 4 patients had complete resolution of the PAL, with a median time from endobronchial valve placement to air leak resolution of 17.5 days, and 6 patients required additional interventions [<a href="#rid27">27</a>].</p><p></p><p class="bulletIndent1">During the coronavirus disease 2019 (COVID-19) pandemic, pneumothorax and PAL have occurred due to a combination of fibrotic parenchymal changes and prolonged high-pressure ventilation. Endobronchial valves have been reported in some case series to help support weaning patients with COVID-19 from mechanical ventilation without the need for more invasive intervention [<a href="#rid28">28-30</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Spigots</strong> – Bronchial occlusion can be achieved with a silicone spigot. Spigots are silicone plugs (not available in the United States) that are available in different sizes (5, 6, and 7 mm; sized according to balloon inflated in the airway segment of interest and confirming air leak decrease/cessation) and have studs on the lateral surface permitting anchorage within the target bronchus. In a case series of 60 patients with APF and PAL who underwent spigot placement (mean number of four spigots per patient), complete resolution of the air leak occurred in 40 percent, and a reduction of the leak occurred in an additional 38 percent [<a href="#rid31">31</a>]. The procedure was complicated by pneumonia (3 percent), dyspnea (3 percent), and fever (1 percent).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Occlusive material</strong> – Anecdotal reports of successful fistula closure using fibrin glue and other sealants (including gelatin sponge and <a class="drug drug_general" data-topicid="10083" href="/z/d/drug information/10083.html" rel="external">oxidized regenerated cellulose</a>) have been reported [<a href="#rid32">32-34</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Airway stents</strong> – Although infrequently used, stents can be placed to occlude the affected lobar bronchus, thus diverting flow away from a target lobe. For example, if the left upper lobe is the target lobe, a fully covered self-expanding metallic stent can be a placed in the left main stem bronchus to the left lower lobe, thereby bypassing the left upper lobe. (See  <a class="medical medical_review" href="/z/d/html/4403.html" rel="external">"Airway stents"</a>.)</p><p></p><p class="headingAnchor" id="H4206417479"><span class="h4">Follow-up</span><span class="headingEndMark"> — </span>During the immediate follow-up period, the clinician should assess for the degree of residual air leak as well as for symptoms of complications of the procedure. Complete success is considered one where the air leak resolves, allowing removal of the chest tube (usually over days), while a partial response is one where the air leak no longer requires suction and is controlled with a water seal. In cases of a partial response, an additional procedure, often the placement of an ambulatory drainage device (such as Heimlich valve, chest drain valve, mobile dry seal drain, or digital chest tube) is performed to achieve successful closure.</p><p>For those who undergo valve placement, follow-up depends on air leak cessation. If the leak resolves, then the chest tube is removed. However, if leak persists, patients are discharged on ambulatory drainage devices and reassessed in two weeks. All patients are reevaluated at six weeks post-air leak cessation, and valves are removed per manufacturer's recommendations. In addition, the clinician should look for symptoms of complications (eg, fever, pneumonia, displacement, and expectoration) during the period where valves are present. A similar protocol is used if plugs were deployed. Plugs also require removal at six weeks post-air leak cessation, whereas occlusive material dissolves with time (usually two weeks postplacement) and does not need removal. (See <a class="local">'Ambulatory drainage devices'</a> below.)</p><p>For those who fail bronchoscopic occlusion of APF (generally six to eight weeks), nonbronchoscopic methods or surgery are options. (See <a class="local">'Surgical repair'</a> below and <a class="local">'Ambulatory drainage devices'</a> below.)</p><p class="headingAnchor" id="H2820599380"><span class="h3">Significant collateral ventilation or minimal reduction of air leak on bronchial occlusion</span><span class="headingEndMark"> — </span>Large APF with PAL associated with significant collateral ventilation with other lobes (eg, ≤90 percent complete (see <a class="local">'Evaluation of fissure completeness'</a> above)) or a &lt;50 reduction in airflow with balloon occlusion (see <a class="local">'Quantifying the air leak'</a> above) are not suitable for bronchoscopic valve treatment of fistula closure alone. Surgical repair and/or additional pleural intervention are typically necessary, depending upon the patient candidacy for surgery.</p><p class="headingAnchor" id="H2026817176"><span class="h4">Surgical repair</span><span class="headingEndMark"> — </span>Surgical intervention is usually considered for patients with spontaneous pneumothorax, those in whom bronchoscopic methods are not suitable or those refractory to bronchoscopic or other nonsurgical procedures. VATS may be used to achieve pleural adhesion with application of sclerosing agents under vision, pleural abrasion, or pleurectomy. Other surgical interventions include over stapling of parenchymal lesions and application of sealants, thoracotomy with muscle or omental flap reinforcement at the site of the leak, pleural tenting, and buttressing of staple lines to obliterate the fistula [<a href="#rid35">35</a>].</p><p class="headingAnchor" id="H4122542064"><span class="h2">Refractory patients</span><span class="headingEndMark"> — </span>For patients who fail or are not candidates for bronchoscopic or surgical approaches, ambulatory drainage devices and nonsurgical pleural procedures are options. They are also considered additive when surgical or bronchoscopic methods achieve a partial response only. Choosing among them should be individualized and depends upon fistula characteristics, local expertise, and patient preference. (See  <a class="medical medical_review" href="/z/d/html/6695.html" rel="external">"Chemical pleurodesis for the prevention of recurrent pleural effusion"</a>.)</p><p class="headingAnchor" id="H3642207944"><span class="h3">Ambulatory drainage devices</span><span class="headingEndMark"> — </span>Chest drain valve  (<a class="graphic graphic_picture graphicRef117642" href="/z/d/graphic/117642.html" rel="external">picture 1</a>), Heimlich valve, mobile dry seal drain  (<a class="graphic graphic_picture graphicRef117643" href="/z/d/graphic/117643.html" rel="external">picture 2</a> and <a class="graphic graphic_picture graphicRef117650" href="/z/d/graphic/117650.html" rel="external">picture 3</a>), and digital chest tube drains are one-way small valves that are applied to a chest tube, allowing patients to ambulate and even facilitating earlier hospital discharge. Chest drain valves, Heimlich valves, and mobile dry seal drains can only be placed once the patient demonstrates no pneumothorax on water seal, while digital chest tube drains can be placed even when the patient requires continuous suction since the system has the capability to provide ambulatory suction (see <a class="local">'Quantifying the air leak'</a> above). Patients can be discharged home with these devices as long as they are asymptomatic without subcutaneous emphysema or enlarging pneumothorax size  (<a class="graphic graphic_table graphicRef117641" href="/z/d/graphic/117641.html" rel="external">table 1</a>).</p><p class="headingAnchor" id="H784545998"><span class="h3">Nonsurgical pleural procedures</span></p><p class="headingAnchor" id="H3838790042"><span class="h4">Chemical pleurodesis</span><span class="headingEndMark"> — </span>Chemical pleurodesis (via medical thoracoscopy or chest tube) using sclerosants such as talc or <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">doxycycline</a> induces an inflammatory response that leads to a scar obliterating the pleural space and allowing for the pleural defect to seal [<a href="#rid1">1</a>]. Retrospective studies report success rates between 60 and 90 percent [<a href="#rid1">1,36</a>]. Successful pleurodesis requires direct apposition of the visceral and parietal pleura and thus should only be done if there is a small or no residual pneumothorax when the chest tube is on water seal; chemical pleurodesis performed with a large pneumothorax may result in failure of the lung to reexpand. Chemical pleurodesis and its complications are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6695.html" rel="external">"Chemical pleurodesis for the prevention of recurrent pleural effusion"</a> and  <a class="medical medical_review" href="/z/d/html/6699.html" rel="external">"Medical thoracoscopy (pleuroscopy): Diagnostic and therapeutic applications", section on 'Blebectomy and/or pleurodesis for pneumothorax'</a>.)</p><p class="headingAnchor" id="H60374392"><span class="h4">Autologous blood patch pleurodesis</span><span class="headingEndMark"> — </span>Autologous blood patch pleurodesis (ABPP) is an alternative technique that has been used in patients with APF and PAL, with or without complete lung expansion. Studies have shown that ABPP is safe and well tolerated by most patients [<a href="#rid37">37-43</a>]. A review of 10 retrospective studies reported a success rate of 92 percent [<a href="#rid37">37</a>].</p><p>A sample of the patient's own blood (usually 100 mL) is directed to the pleural space via the chest tube followed by 20 mL of <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">saline</a>. The chest tube is then hung over an intravenous pole (for one to two hours) to avoid drainage of blood and blockage to the tube with thrombus, which could induce a tension pneumothorax, particularly in those who require suction for pleural apposition.</p><p>The proposed mechanism of action is likely due to direct sealing of the air leak as well as the induction of pleural inflammation and eventual pleurodesis. The optimum blood required to achieve successful pleurodesis is unknown and ranges from 50 to 120 mL. However, studies have shown that patients who received 100 to 120 mL of blood achieved complete resolution of PAL faster and more successfully compared with lower blood volumes (50 to 60 mL) [<a href="#rid37">37-40</a>]. Thus, we prefer use of higher volumes of blood for this procedure.</p><p>Complications occur in &lt;10 percent of cases and include pleuritis, empyema, and chest tube obstruction [<a href="#rid40">40</a>].</p><p class="headingAnchor" id="H1375112500"><span class="h2">Special populations</span></p><p class="headingAnchor" id="H3905999500"><span class="h3">Patients with spontaneous pneumothorax</span><span class="headingEndMark"> — </span>Patients with primary spontaneous pneumothorax, particularly those with failed lung reexpansion who have PAL, are generally treated with VATS surgical pleurodesis, a practice that is consistent with most guidelines [<a href="#rid44">44-46</a>]. Patients with secondary pneumothorax also, typically, undergo surgical pleurodesis, although valves may be an option in those not fit for surgery [<a href="#rid47">47-49</a>]. (See  <a class="medical medical_review" href="/z/d/html/117232.html" rel="external">"Treatment of primary spontaneous pneumothorax in adults"</a> and  <a class="medical medical_review" href="/z/d/html/6691.html" rel="external">"Treatment of secondary spontaneous pneumothorax in adults"</a>.)</p><p class="headingAnchor" id="H3574369181"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>An alveolopleural fistula (APF) is a pathologic communication between the pulmonary parenchyma distal to a segmental bronchus (alveoli) and the pleural space. An air leak for greater than five days noticed on chest tube is called a prolonged air leak (PAL). (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>APF with PALs are most commonly seen in patients following lung volume reduction surgery and pulmonary resection (typically wedge resection or biopsy) but can also be seen following spontaneous pneumothorax. Less common causes include pulmonary infections, malignancies, pleural drainage procedures, mechanical ventilation, and chest trauma. (See <a class="local">'Etiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For most patients with PAL, we suggest conservative measures rather than aggressive interventions  (<a class="graphic graphic_algorithm graphicRef117795" href="/z/d/graphic/117795.html" rel="external">algorithm 1</a>) (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). (See <a class="local">'General supportive care (drainage of air)'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Conservative therapy involves continued chest tube thoracostomy and low wall suction in those with expandable lung; a second chest tube may be warranted in those with large leaks, while suction should be avoided in those with nonexpandable lung.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Other therapies include optimization of nutrition and therapy for comorbidities and lowering the level of positive pressure and selective intubation of the healthy lung in those who are mechanically ventilated.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The exception to this rule is patients with PAL due to spontaneous pneumothorax, in whom video-assisted thoracoscopic blebectomy and pleurodesis, rather than conservative measures, are preferred. (See <a class="local">'Special populations'</a> above and  <a class="medical medical_review" href="/z/d/html/117888.html" rel="external">"Pneumothorax: Definitive management and prevention of recurrence"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For patients who fail conservative therapy, we prefer a systematic approach using quantitative or semiquantitative air leak, bronchial occlusion, and computed tomography techniques that measure the size and location of the APF and the integrity of the interlobar fissure adjacent to the APF  (<a class="graphic graphic_algorithm graphicRef117795" href="/z/d/graphic/117795.html" rel="external">algorithm 1</a>). (See <a class="local">'Patients who fail supportive care'</a> above and <a class="local">'Quantifying the air leak'</a> above and <a class="local">'Localizing the air leak (sequential balloon occlusion)'</a> above and <a class="local">'Evaluation of fissure completeness'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For patients with APF associated with minimal collateral ventilation (eg, interlobar fissure &gt;90 percent complete) and significant (eg, ≥50 percent) reduction of the leak on bronchial occlusion, we suggest bronchoscopic therapy rather than continued conservative therapy, surgery, ambulatory drainage devices, or pleural procedures (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). No bronchoscopic method is superior, but we prefer endobronchial valve placement rather than spigots or occlusive materials based upon the rationale that they are easily placed/removed, better studied, and approved as a humanitarian use device. (See <a class="local">'Minimal collateral ventilation and significant air leak reduction on bronchial occlusion'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For patients with significant collateral ventilation (eg, interlobar fissure ≤90 percent complete) or minimal reduction of the leak on bronchial occlusion (eg, &lt;50 percent), we suggest surgical repair rather than continued conservative therapy, bronchoscopic interventions, ambulatory devices, or pleural procedures (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). (See <a class="local">'Significant collateral ventilation or minimal reduction of air leak on bronchial occlusion'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For patients who fail or are not candidates for bronchoscopic or surgical approaches, ambulatory drainage devices and nonsurgical pleural procedures are options (eg, blood patch or chemical pleurodesis). They are also considered additive when surgical or bronchoscopic methods achieve a partial response only. Choosing among them should be individualized and depends upon fistula size, local expertise, and patient preference. (See <a class="local">'Refractory patients'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Liberman M, Muzikansky A, Wright CD, et al. Incidence and risk factors of persistent air leak after major pulmonary resection and use of chemical pleurodesis. Ann Thorac Surg 2010; 89:891.</a></li><li><a class="nounderline abstract_t">DeCamp MM, Blackstone EH, Naunheim KS, et al. Patient and surgical factors influencing air leak after lung volume reduction surgery: lessons learned from the National Emphysema Treatment Trial. Ann Thorac Surg 2006; 82:197.</a></li><li><a class="nounderline abstract_t">Rivera C, Bernard A, Falcoz PE, et al. Characterization and prediction of prolonged air leak after pulmonary resection: a nationwide study setting up the index of prolonged air leak. Ann Thorac Surg 2011; 92:1062.</a></li><li><a class="nounderline abstract_t">Stolz AJ, Schützner J, Lischke R, et al. Predictors of prolonged air leak following pulmonary lobectomy. Eur J Cardiothorac Surg 2005; 27:334.</a></li><li><a class="nounderline abstract_t">Muriana P, Rossetti F, Viscardi S, et al. Prolonged air leak after robotic lung resection: a narrative review. J Thorac Dis 2023; 15:909.</a></li><li><a class="nounderline abstract_t">Bishop MJ, Benson MS, Pierson DJ. Carbon dioxide excretion via bronchopleural fistulas in adult respiratory distress syndrome. Chest 1987; 91:400.</a></li><li><a class="nounderline abstract_t">Chopra A, Doelken P, Judson MA, Huggins T. The pressure-dependent air leak after partial lung resection. Thorax 2017; 72:290.</a></li><li><a class="nounderline abstract_t">Heidecker J, Huggins JT, Sahn SA, Doelken P. Pathophysiology of pneumothorax following ultrasound-guided thoracentesis. Chest 2006; 130:1173.</a></li><li><a class="nounderline abstract_t">Chopra A, Hu K, Judson MA, et al. Association between Drainage-Dependent Prolonged Air Leak after Partial Lung Resection and Clinical Outcomes: A Prospective Cohort Study. Ann Am Thorac Soc 2022; 19:389.</a></li><li><a class="nounderline abstract_t">Cerfolio RJ, Tummala RP, Holman WL, et al. A prospective algorithm for the management of air leaks after pulmonary resection. Ann Thorac Surg 1998; 66:1726.</a></li><li><a class="nounderline abstract_t">Cerfolio RJ, Bass C, Katholi CR. Prospective randomized trial compares suction versus water seal for air leaks. Ann Thorac Surg 2001; 71:1613.</a></li><li><a class="nounderline abstract_t">Brunelli A, Salati M, Pompili C, et al. Regulated tailored suction vs regulated seal: a prospective randomized trial on air leak duration. Eur J Cardiothorac Surg 2013; 43:899.</a></li><li><a class="nounderline abstract_t">Alphonso N, Tan C, Utley M, et al. A prospective randomized controlled trial of suction versus non-suction to the under-water seal drains following lung resection. Eur J Cardiothorac Surg 2005; 27:391.</a></li><li><a class="nounderline abstract_t">Rathinam S, Bradley A, Cantlin T, Rajesh PB. Thopaz Portable Suction Systems in Thoracic Surgery: an end user assessment and feedback in a tertiary unit. J Cardiothorac Surg 2011; 6:59.</a></li><li><a class="nounderline abstract_t">Aldaghlawi F, Kurman JS, Lilly JA, et al. A Systematic Review of Digital vs Analog Drainage for Air Leak After Surgical Resection or Spontaneous Pneumothorax. Chest 2020; 157:1346.</a></li><li><a class="nounderline abstract_t">Zisis C, Tsirgogianni K, Lazaridis G, et al. Chest drainage systems in use. Ann Transl Med 2015; 3:43.</a></li><li><a class="nounderline abstract_t">Ratliff JL, Hill JD, Tucker H, Fallat R. Endobronchial control of bronchopleural fistulae. Chest 1977; 71:98.</a></li><li><a class="nounderline abstract_t">Firlinger I, Stubenberger E, Müller MR, et al. Endoscopic one-way valve implantation in patients with prolonged air leak and the use of digital air leak monitoring. Ann Thorac Surg 2013; 95:1243.</a></li><li><a class="nounderline abstract_t">Kheir F, Rivera E, Majid A. An Adolescent with Dyspnea and Cough. A Case of Congenital Tracheal Stenosis. Am J Respir Crit Care Med 2017; 196:e30.</a></li><li><a class="nounderline abstract_t">Tian Q, Qi F, An Y, et al. Using the Chartis system to selectively target a lung segment with a persistent air leak. Eur Respir J 2013; 41:1461.</a></li><li><a class="nounderline abstract_t">Travaline JM, McKenna RJ Jr, De Giacomo T, et al. Treatment of persistent pulmonary air leaks using endobronchial valves. Chest 2009; 136:355.</a></li><li><a class="nounderline abstract_t">El-Sameed Y, Waness A, Al Shamsi I, Mehta AC. Endobronchial valves in the management of broncho-pleural and alveolo-pleural fistulae. Lung 2012; 190:347.</a></li><li><a class="nounderline abstract_t">Reed MF, Gilbert CR, Taylor MD, Toth JW. Endobronchial Valves for Challenging Air Leaks. Ann Thorac Surg 2015; 100:1181.</a></li><li><a class="nounderline abstract_t">Mahajan AK, Verhoef P, Patel SB, et al. Intrabronchial valves: a case series describing a minimally invasive approach to bronchopleural fistulas in medical intensive care unit patients. J Bronchology Interv Pulmonol 2012; 19:137.</a></li><li><a class="nounderline abstract_t">Vicencio AG, Tozzi M, Thompson C, et al. Intrabronchial valves for treatment of alveolar-pleural fistula in a patient with Pneumocystis jirovecii pneumonia. J Bronchology Interv Pulmonol 2014; 21:346.</a></li><li><a class="nounderline abstract_t">Gilbert CR, Casal RF, Lee HJ, et al. Use of One-Way Intrabronchial Valves in Air Leak Management After Tube Thoracostomy Drainage. Ann Thorac Surg 2016; 101:1891.</a></li><li><a class="nounderline abstract_t">Majid A, Kheir F, Sierra-Ruiz M, et al. Assessment of Fissure Integrity in Patients With Intrabronchial Valves for Treatment of Prolonged Air Leak. Ann Thorac Surg 2019; 107:407.</a></li><li><a class="nounderline abstract_t">Nugent TS, Aladaileh M, Donlon NE, et al. Endobronchial valve use in COVID-19 related pneumothorax and persistent air leak. Ann R Coll Surg Engl 2022; 104:e137.</a></li><li><a class="nounderline abstract_t">Donatelli P, Trentacosti F, Pellegrino MR, et al. Endobronchial valve positioning for alveolar-pleural fistula following ICU management complicating COVID-19 pneumonia. BMC Pulm Med 2021; 21:307.</a></li><li><a class="nounderline abstract_t">Ahmed H, Badran A, Tamburrini A, et al. Endobronchial Valves in the Management of Persistent Air Leak in Coronavirus Disease 2019. Ann Thorac Surg 2022; 113:e1.</a></li><li><a class="nounderline abstract_t">Watanabe Y, Matsuo K, Tamaoki A, et al.. Bronchial Occlusion with endobronchial Watanabe spigot. Journal of Bronchology 2003; 10:264.</a></li><li><a class="nounderline abstract_t">Dugan KC, Laxmanan B, Murgu S, Hogarth DK. Management of Persistent Air Leaks. Chest 2017; 152:417.</a></li><li><a class="nounderline abstract_t">Jones DP, David I. Gelfoam occlusion of peripheral bronchopleural fistulas. Ann Thorac Surg 1986; 42:334.</a></li><li><a class="nounderline abstract_t">Sprung J, Krasna MJ, Yun A, et al. Treatment of a bronchopleural fistula with a Fogarty catheter and oxidized regenerated cellulose (surgicel). Chest 1994; 105:1879.</a></li><li><a class="nounderline abstract_t">Mueller MR, Marzluf BA. The anticipation and management of air leaks and residual spaces post lung resection. J Thorac Dis 2014; 6:271.</a></li><li><a class="nounderline abstract_t">How CH, Tsai TM, Kuo SW, et al. Chemical pleurodesis for prolonged postoperative air leak in primary spontaneous pneumothorax. J Formos Med Assoc 2014; 113:284.</a></li><li><a class="nounderline abstract_t">Chambers A, Routledge T, Billè A, Scarci M. Is blood pleurodesis effective for determining the cessation of persistent air leak? Interact Cardiovasc Thorac Surg 2010; 11:468.</a></li><li><a class="nounderline abstract_t">Aihara K, Handa T, Nagai S, et al. Efficacy of blood-patch pleurodesis for secondary spontaneous pneumothorax in interstitial lung disease. Intern Med 2011; 50:1157.</a></li><li><a class="nounderline abstract_t">Ando M, Yamamoto M, Kitagawa C, et al. Autologous blood-patch pleurodesis for secondary spontaneous pneumothorax with persistent air leak. Respir Med 1999; 93:432.</a></li><li><a class="nounderline abstract_t">Manley K, Coonar A, Wells F, Scarci M. Blood patch for persistent air leak:  a review of the current literature. Curr Opin Pulm Med 2012; 18:333.</a></li><li><a class="nounderline abstract_t">Oliveira FH, Cataneo DC, Ruiz RL Jr, Cataneo AJ. Persistent pleuropulmonary air leak treated with autologous blood: results from a university hospital and review of literature. Respiration 2010; 79:302.</a></li><li><a class="nounderline abstract_t">Ozpolat B. Autologous blood patch pleurodesis in the management of prolonged air leak. Thorac Cardiovasc Surg 2010; 58:52.</a></li><li><a class="nounderline abstract_t">Cagirici U, Sahin B, Cakan A, et al. Autologous blood patch pleurodesis in spontaneous pneumothorax with persistent air leak. Scand Cardiovasc J 1998; 32:75.</a></li><li><a class="nounderline abstract_t">Tschopp JM, Bintcliffe O, Astoul P, et al. ERS task force statement: diagnosis and treatment of primary spontaneous pneumothorax. Eur Respir J 2015; 46:321.</a></li><li><a class="nounderline abstract_t">Baumann MH, Strange C, Heffner JE, et al. Management of spontaneous pneumothorax: an American College of Chest Physicians Delphi consensus statement. Chest 2001; 119:590.</a></li><li><a class="nounderline abstract_t">Roberts ME, Rahman NM, Maskell NA, et al. British Thoracic Society Guideline for pleural disease. Thorax 2023; 78:s1.</a></li><li><a class="nounderline abstract_t">Toma TP, Kon OM, Oldfield W, et al. Reduction of persistent air leak with endoscopic valve implants. Thorax 2007; 62:830.</a></li><li><a class="nounderline abstract_t">Anile M, Venuta F, De Giacomo T, et al. Treatment of persistent air leakage with endobronchial one-way valves. J Thorac Cardiovasc Surg 2006; 132:711.</a></li><li><a class="nounderline abstract_t">Santini M, Fiorelli A, Vicidomini G, et al. Iatrogenic air leak successfully treated by bronchoscopic placement of unidirectional endobronchial valves. Ann Thorac Surg 2010; 89:2007.</a></li></ol></div><div id="topicVersionRevision">Topic 116036 Version 20.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20172150" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Incidence and risk factors of persistent air leak after major pulmonary resection and use of chemical pleurodesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16798215" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Patient and surgical factors influencing air leak after lung volume reduction surgery: lessons learned from the National Emphysema Treatment Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21871301" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Characterization and prediction of prolonged air leak after pulmonary resection: a nationwide study setting up the index of prolonged air leak.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15691692" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Predictors of prolonged air leak following pulmonary lobectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36910080" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Prolonged air leak after robotic lung resection: a narrative review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3102170" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Carbon dioxide excretion via bronchopleural fistulas in adult respiratory distress syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27672119" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : The pressure-dependent air leak after partial lung resection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17035453" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Pathophysiology of pneumothorax following ultrasound-guided thoracentesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34715010" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Association between Drainage-Dependent Prolonged Air Leak after Partial Lung Resection and Clinical Outcomes: A Prospective Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9875779" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : A prospective algorithm for the management of air leaks after pulmonary resection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11383809" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Prospective randomized trial compares suction versus water seal for air leaks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23024236" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Regulated tailored suction vs regulated seal: a prospective randomized trial on air leak duration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15740944" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : A prospective randomized controlled trial of suction versus non-suction to the under-water seal drains following lung resection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21510897" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Thopaz Portable Suction Systems in Thoracic Surgery: an end user assessment and feedback in a tertiary unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31958444" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : A Systematic Review of Digital vs Analog Drainage for Air Leak After Surgical Resection or Spontaneous Pneumothorax.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25815304" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Chest drainage systems in use.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/830511" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Endobronchial control of bronchopleural fistulae.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23434254" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Endoscopic one-way valve implantation in patients with prolonged air leak and the use of digital air leak monitoring.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28683205" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : An Adolescent with Dyspnea and Cough. A Case of Congenital Tracheal Stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23728409" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Using the Chartis system to selectively target a lung segment with a persistent air leak.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19349382" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Treatment of persistent pulmonary air leaks using endobronchial valves.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22246554" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Endobronchial valves in the management of broncho-pleural and alveolo-pleural fistulae.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26219689" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Endobronchial Valves for Challenging Air Leaks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23207358" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Intrabronchial valves: a case series describing a minimally invasive approach to bronchopleural fistulas in medical intensive care unit patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25321456" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Intrabronchial valves for treatment of alveolar-pleural fistula in a patient with Pneumocystis jirovecii pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26876341" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Use of One-Way Intrabronchial Valves in Air Leak Management After Tube Thoracostomy Drainage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30315804" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Assessment of Fissure Integrity in Patients With Intrabronchial Valves for Treatment of Prolonged Air Leak.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34730417" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Endobronchial valve use in COVID-19 related pneumothorax and persistent air leak.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34579700" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Endobronchial valve positioning for alveolar-pleural fistula following ICU management complicating COVID-19 pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34492216" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Endobronchial Valves in the Management of Persistent Air Leak in Coronavirus Disease 2019.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Bronchial Occlusion with endobronchial Watanabe spigot</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28267436" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Management of Persistent Air Leaks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3753084" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Gelfoam occlusion of peripheral bronchopleural fistulas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8205897" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Treatment of a bronchopleural fistula with a Fogarty catheter and oxidized regenerated cellulose (surgicel).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24624291" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : The anticipation and management of air leaks and residual spaces post lung resection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24746114" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Chemical pleurodesis for prolonged postoperative air leak in primary spontaneous pneumothorax.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20628018" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Is blood pleurodesis effective for determining the cessation of persistent air leak?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21628929" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Efficacy of blood-patch pleurodesis for secondary spontaneous pneumothorax in interstitial lung disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10464827" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Autologous blood-patch pleurodesis for secondary spontaneous pneumothorax with persistent air leak.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22498731" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Blood patch for persistent air leak:  a review of the current literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19556743" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Persistent pleuropulmonary air leak treated with autologous blood: results from a university hospital and review of literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20072980" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Autologous blood patch pleurodesis in the management of prolonged air leak.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9636962" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Autologous blood patch pleurodesis in spontaneous pneumothorax with persistent air leak.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26113675" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : ERS task force statement: diagnosis and treatment of primary spontaneous pneumothorax.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11171742" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Management of spontaneous pneumothorax: an American College of Chest Physicians Delphi consensus statement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37433578" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : British Thoracic Society Guideline for pleural disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17726171" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Reduction of persistent air leak with endoscopic valve implants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16935144" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Treatment of persistent air leakage with endobronchial one-way valves.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20494069" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Iatrogenic air leak successfully treated by bronchoscopic placement of unidirectional endobronchial valves.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
